BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Global Health Ltd. Share Price

NSE
BSE

NSE : MEDANTA

BSE : 543654

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹1,334.80

High

₹1,408.10

Price Summary

Previous Close ₹1,401.40
Day's Range ₹1,334.80 - ₹1,408.10
Open ₹1,390.00
52 Week Range ₹956.00 - ₹1,456.50
Volume 3,39,486
Market Cap ₹0.04
Previous Close ₹1,399.85
Day's Range ₹1,337.20 - ₹1,404.05
Open ₹1,399.95
52 Week Range ₹955.20 - ₹1,455.85
Volume 14,183
Market Cap ₹0.04

Stocks Summary

Trade Value ( ₹ in Lacs) 4,757.56
Market Cap (₹ in Mn) 0.04
Dividend Yield(%) 0.04
Price/Earning (TTM) 68.43
TTM EPS (₹) 20.69
P/E Ratio 66.85
Book Value(₹) 9.59
PAT Margin (%) 13.04
Face Value (₹) 2.00
ROCE(%) 20.50
Trade Value ( ₹ in Lacs) 198.54
Market Cap (₹ in Mn) 0.04
Dividend Yield(%) 0.04
Price/Earning (TTM) 68.43
TTM EPS (₹) 20.69
P/E Ratio 66.85
Book Value(₹) 9.59
PAT Margin (%) 13.04
Face Value (₹) 2.00
ROCE(%) 20.50

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 10308.44 32041.46
Expenses N/A N/A
PBT 2081.41 6230.47
Operating profit 0.0 0.0
Net profit 1589.82 4615.28

Shareholding Pattern

Promoters (% Holding)

33.00%

Mutual funds (% Holding)

16.03%

Non-Institution (% Holding)

40.65%

FI/Banks/Insurance (% Holding)

0.66%

Government (% Holding)

0.00%

FII

9.46%

About Global Health Ltd.

Founded 2004
Managing Director Naresh Trehan
NSE Symbol MEDANTA

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,80,046.94 2,033.60 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 2,08,140.64 8,035.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,85,263.87 5,096.35 3,480.60 - 3,480.60
Apollo Hospitals Enterprise Ltd. 1,29,210.64 8,961.55 6,696.50 - 6,696.50
Cipla Ltd. 1,18,430.12 1,475.50 1,165.70 - 1,165.70
Zydus Lifesciences Ltd. 1,11,271.55 1,119.75 835.50 - 835.50
Lupin Ltd. 1,10,609.69 2,417.00 1,836.80 - 1,836.80
Max Healthcare Institute Ltd. 1,09,639.25 1,113.00 903.00 - 903.00
Mankind Pharma Ltd. 1,06,427.00 2,476.05 1,909.70 - 1,909.70
Lenskart Solutions Ltd. 97,942.13 567.80 0.00 - 0.00
no-content No Records Found

Latest News

Jun
18
2026
EQUITY Posted on Jun 18th 2026

Global Health informs about analyst meet

Global Health has informed that the Company’s Management will meet Investors/Analysts in Meetings organised by Nuvama Institutional Equities as on June 24, 2026, June 25, 2026 and June 26, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
11
2026
EQUITY Posted on May 11th 2026

Global Health informs about updates

Global Health has informed that the Nomination and Remuneration Committee of Global Health (‘the Company’) in its meeting held today, May 11, 2026, has approved the grant of 10,000 ESOPs to one employee under Part –A of GHL LTIP 2024 Plan; GHL Employees Stock Option Scheme, 2024. Necessary disclosure in this regard as mandated under the Listing Regulations is attached as Annexure. The meeting of the Nomination & Remuneration Committee commenced at 10.45 AM and concluded at 11:35 AM.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
31
2026
EQUITY Posted on Jul 31st 2026

Shelter Pharma informs about appointment of director

Shelter Pharma has informed that Board of Directors of the Company at its meeting held today, Friday, 31st July, 2026 approved appointment of Vinita Shivraj Gadhvi as an Additional Independent Director pursuant to the provisions of Sections 149, 152, and 161(1) read with Schedule IV of the Companies Act, 2013, and based on the recommendation of the Nomination and Remuneration Committee. Her tenure is fixed for a period of five consecutive years with effect from 31st July, 2026, subject to the approval of the shareholders of the Company during which she will not be liable to retire by rotation. The aforesaid Director are not related to any Director or Key Managerial Personnel on the Board of the Company. Further the Director is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
31
2026
EQUITY Posted on Jul 31st 2026

Divi's Laboratories informs about cessation of SMP

Divi's Laboratories has informed that L. Ramesh Babu, Vice President (Procurement) and D. Madhu Babu, Vice President (Projects) of the Company will be retiring from the close of business hours on July 31, 2026, and will cease to be Senior Management Personnel (SMP) of the Company. The details required under Regulation 30 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure – I.

The above information is a part of company’s filings submitted to BSE.

Read More
Jul
31
2026
COMPANY Posted on Jul 31st 2026

Colinz Laboratories - Quaterly Results

A decrease in the sales to Rs. 12.41 millions was observed for the quarter ended June 2026. The sales stood at Rs. 15.66 millions during the similar quarter previous year.Net Profit witnessed a 1934.75% growth almost the double from Rs. 1.18 millions to Rs. 24.01  millions  of same quarter last year.The company reported a degrowth in operating Profit to 1.84 millions from 2.11 millions.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 12.41 15.66 -20.75 12.41 15.66 -20.75 61.36 65.28 -6.00
Other Income 1.22 0.75 62.67 1.22 0.75 62.67 4.84 2.98 62.42
PBIDT 1.84 2.11 -12.80 1.84 2.11 -12.80 8.91 7.94 12.22
Interest 0.07 0.12 -41.67 0.07 0.12 -41.67 0.47 0.42 11.90
PBDT 29.40 1.99 1377.39 29.40 1.99 1377.39 8.44 7.52 12.23
Depreciation 0.39 0.39 0.00 0.39 0.39 0.00 1.56 1.31 19.08
PBT 29.01 1.60 1713.13 29.01 1.60 1713.13 6.88 6.21 10.79
TAX 5.00 0.42 1090.48 5.00 0.42 1090.48 1.75 1.23 42.28
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.15 -0.52 -71.15
PAT 24.01 1.18 1934.75 24.01 1.18 1934.75 5.13 4.98 3.01
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 14.83 13.47 10.04 14.83 13.47 10.04 14.52 12.16 19.39
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Global Health Ltd. ?

The current share price of Global Health Ltd. is ₹1,401.40 as of 2026-07-31.

The market capitalisation of Global Health Ltd. is ₹38,061.49 as of 2026-07-30.

The 1-year return of Global Health Ltd. is 95.10% as of 2026-07-31.

The P/E ratio of Global Health Ltd. is 66.85 as of 2026-07-31.

The 52-week high and low of Global Health Ltd. are ₹1,456.50 and ₹956.00, respectively, as of 2026-07-31.

The dividend yield of Global Health Ltd. is 0.0353% as of2026-07-30.

You can buy Global Health Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Global Health Ltd. is Naresh Trehan.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore